ELAB vs UPST · rev $2.0M vs P/E 74, rev $672.9M
Elevai Labs, Inc. Common Stock (ELAB) versus Upstart Holdings Inc (UPST) — a side-by-side from cached financials, not a winner call.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
Upstart Holdings Inc (UPST) is a credit services company listed on NASDAQ.
Latest reported ELAB revenue for 2026-06-30 was $2.0M. Net income was -$7.9M. ELAB currently screens at market cap $6.5M.
Latest reported UPST revenue for 2026-06-30 was $672.9M. Net income was $9.9M. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
ELAB currently screens at market cap $6.5M. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
Not investment advice. Open the ELAB and UPST stock pages for the full models.
Not investment advice.